Act1 in CD40-/BAFFR-Mediated B Cell Survival
Act1 in CD40-/BAFFR-Mediated B Cell Survival
批准号:
6954559
负责人:
Xiaoxia Li
金额:
$32.51万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-06-15 至 2010-02-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Throughout development, maturation and activation, B cells are continuously exposed to two major opposing forces. The first is the drive to generate and maintain B cells with highly diverse immune receptors able to recognize the diversity of exogenous antigens. The second is the necessity to avoid damaging immune responses against self-components. The balance of these two forces ensures an inability to react to self-antigens while preserving defenses against pathogens. CD40-CD40L and BAFF-BAFFR cytokine pathways have been shown to play essential roles in B cell survival and differentiation. We investigated the regulatory mechanism of a novel adaptor molecule, termed Act1 in CD40 and BAFFR-mediated B cell survival. We found that CD40- and BAFF-mediated survival is significantly increased in Act1-deficient B cells. Consistent with this finding, Act1-deficient mice revealed a general increase in peripheral B cells, culminating in lymphadenopathy, splenomegaly, and the formation of autoantibodies. Act1 exerts its negative regulatory function in B cell survival through its direct impact on the immediate signaling events mediated by CD40 and BAFF. Act1-deficient B cells displayed enhanced CD40L- and BAFF-induced IkappaB phosphorylation and processing of NF-kappaB2(pl00/p52). Based on these findings, we hypothesize that Act1 is an important regulator for the homeostasis of B cells by attenuating CD40 and BAFFR signaling, modulating humoral immune responses. To test this hypothesis, we will first elucidate the mechanism by which Act1 negatively regulates the CD40- and BAFFR-mediated signaling (Specific Aim 1). We will then examine Investigate the physiological and pathological impact of the Act1-regulated pathways on B cell survival and humoral immune responses (Specific Aim 2). These proposed studies will provide us with the mechanistic insight for Act1's function, revealing how Act1 coordinately regulates CD40- and BAFFR-mediated pathways, thereby exerting its impact on B cell survival and modulating humoral immune responses. These findings will help us to elucidate the detailed regulatory mechanism for B cell homeostasis and opens new possibility to intervene the immune system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core B: Animal Model and Immunotyping Core
-
批准号:10493942
-
项目类别:
-
资助金额:$39.26万
-
财政年份:2022
-
负责人:Xiaoxia Li
-
依托单位:
IL-17-driven mechanisms for tumor progression and resistance to therapies
-
批准号:10493940
-
项目类别:
-
资助金额:$52.03万
-
财政年份:2022
-
负责人:Xiaoxia Li
-
依托单位:
The role of TRAF4 E3 ligase in IL-25-mediated allergic asthma
-
批准号:10112955
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2020
-
负责人:Xiaoxia Li
-
依托单位:
GSDMD-dependent IL-1 signaling in intestinal inflammation
-
批准号:10024455
-
项目类别:
-
资助金额:$54.17万
-
财政年份:2020
-
负责人:Xiaoxia Li
-
依托单位:
The role of TRAF4 E3 ligase in IL-25-mediated allergic asthma
-
批准号:9885028
-
项目类别:
-
资助金额:$40.17万
-
财政年份:2020
-
负责人:Xiaoxia Li
-
依托单位:
IRAKM and Mincle in ALD
-
批准号:9067893
-
项目类别:
-
资助金额:$43.81万
-
财政年份:2015
-
负责人:Xiaoxia Li
-
依托单位:
IRAKM and Mincle in ALD
-
批准号:8912063
-
项目类别:
-
资助金额:$43.81万
-
财政年份:2015
-
负责人:Xiaoxia Li
-
依托单位:
Myeloid cells, aging and the metabolic syndrome
-
批准号:8702069
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2013
-
负责人:Xiaoxia Li
-
依托单位:
Myeloid cells, aging and the metabolic syndrome
-
批准号:8611557
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2013
-
负责人:Xiaoxia Li
-
依托单位:
Molecular mechanisms of IL-1R-TLR mediated signaling
-
批准号:8242732
-
项目类别:
-
资助金额:$26.11万
-
财政年份:2011
-
负责人:Xiaoxia Li
-
依托单位:
Molecular and Cellular Mechanisms of IL-17 Signaling
-
批准号:8453438
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2011
-
负责人:Xiaoxia Li
-
依托单位:
Molecular and Cellular Mechanisms of IL-17 Signaling
-
批准号:8642677
-
项目类别:
-
资助金额:$38.21万
-
财政年份:2011
-
负责人:Xiaoxia Li
-
依托单位:
Molecular and Cellular Mechanisms of IL-17 Signaling
-
批准号:8241905
-
项目类别:
-
资助金额:$38.6万
-
财政年份:2011
-
负责人:Xiaoxia Li
-
依托单位:
Molecular and Cellular Mechanisms of IL-17 Signaling
-
批准号:8105532
-
项目类别:
-
资助金额:$38.6万
-
财政年份:2011
-
负责人:Xiaoxia Li
-
依托单位:
Molecular Mechanisms for IL-25-mediated Th2 Responses
-
批准号:7989486
-
项目类别:
-
资助金额:$35.9万
-
财政年份:2010
-
负责人:Xiaoxia Li
-
依托单位:
SIGIRR-mediated Tumor Suppression
-
批准号:8052294
-
项目类别:
-
资助金额:$49.37万
-
财政年份:2010
-
负责人:Xiaoxia Li
-
依托单位:
Colitis and Colitis Associate Cancer Core
-
批准号:8052300
-
项目类别:
-
资助金额:$17.71万
-
财政年份:2010
-
负责人:Xiaoxia Li
-
依托单位:
Molecular mechanisms of IL-1R-TLR mediated signaling
-
批准号:7659831
-
项目类别:
-
资助金额:$44.89万
-
财政年份:2009
-
负责人:Xiaoxia Li
-
依托单位:
SIGIRR A Negative Regulator of Toll-IL-IR Signaling
-
批准号:6927702
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2005
-
负责人:Xiaoxia Li
-
依托单位:
SIGIRR A Negative Regulator of Toll-IL-IR Signaling
-
批准号:7371070
-
项目类别:
-
资助金额:$35.58万
-
财政年份:2005
-
负责人:Xiaoxia Li
-
依托单位: